Jurnal Ilmu Farmasi & Farmasi Klinik Journal of Pharmaceutical Science & Clinical Pharmacy

Jurnal Ilmu Farmasi & Farmasi Klinik Journal of Pharmaceutical Science & Clinical Pharmacy Pemimpin Umum/ Penanggung jawab Dekan Fakultas Farmasi Universitas Wahid Hasyim Pemimpin Redaksi Ketua Program Studi Farmasi Fakultas Farmasi Universitas Wahid Hasyim Dewan Penyunting Jurnal Dr. Yulias Ninik W., M.Si., Apt. Redaktur Ahli Dr. Ahmad Ainur Rofiq, M.Si., Apt. (Universitas Sebelas Maret), Burhan Ma’arif Zaenal Arifn, M.Farm. Apt. (UIN Maulana Malik Ibrahim), Dr. Isnaeni, M.S., Apt. (Universitas Airlangga), Kuni Zu’aimah Barikah, M.Farm., Apt. (Universitas Jember), Dr. Nurkhasanah, M.Si., Apt. (Universitas Ahmad Dahlan), Khoerul Anwar, M.Sc., Apt. (Universitas Lambung Mangkurat), Dr. Gunawan Pamudji Widodo, M.Si., Apt. (Universitas Setia Budi), Dr. Laela Hayu Nurani, M.Si., Apt. (Universitas Ahmad Dahlan), Dr. Iis Wahyuningsih, M.Si., Apt. (Universitas Ahmad Dahlan), Dr. Wahyu Widyaningsih, M.Si., Apt. (Universitas Ahmad Dahlan), Muhammad Ikhwan Rizki, M.Farm., Apt. (Universitas Lambung Mangkurat), Dr. Yulias Ninik W., M.Si., Apt. (Universitas Wahid Hasyim), Maulita Cut Nuria, M.Sc., Apt. (Universitas Wahid Hasyim), Yance Anas, M.Sc., Apt. (Universitas Wahid Hasyim), Risha Fillah Fithria, M.Sc., Apt. (Universitas Wahid Hasyim), Aqnes Budiarti, S.F..Sc., Apt. (Universitas Wahid Hasyim), Ririn Lispita Wulandari, M.Si.Med., Apt. (Universitas Wahid Hasyim), Maria Ulfah, M.Sc., Apt. (Universitas Wahid Hasyim), Elya Zulfa, M.Sc., Apt. (Universitas Wahid Hasyim), Anita Dwi Puspitasari, S.Si., M.Pd. (Universitas Wahid Hasyim), Dewi Andini Kunti Mulangsri, M.Farm., Apt. (Universitas Wahid Hasyim), Devi Nisa Hidayati, M.Sc., Apt (Universitas Wahid Hasyim), M. Fatchur Rochman, M.Farm. (Universitas Wahid Hasyim), Malinda Prihantini, M.Si., Apt. (Universitas Wahid Hasyim) Redaktur Pelaksana Elya Zulfa, S.Farm., M.Sc., Apt Staf Redaksi : Dewi Andini Kunti Mulangsri, M.Farm., Apt. Ririn Lispita W., S. Farm., M.Si.Med, Apt. Devi Nisa Hidayati, M.Sc., Apt Danang Novianto, S.Farm., Apt Erika Indah Safitri, M.Farm. Imam Asrofi, S.Farm. Distributor Fahmi Wildasani, A.Md Alamat Redaksi/Tata Usaha Fakultas Farmasi Universitas Wahid Hasyim Jl. Menoreh Tengah X/22 Sampangan Semarang Telp. 024-8505680, 8505681 Fax. 024-8505680 E-mail : [email protected] Terbit 2 kali setahun sejak September 2004

EFEKTIVITAS FRAKSI AKTIF EKSTRAK ETANOL LABU SIAM (Sechium edule (Jack) Sw) SEBAGAI ANTIHIPERTENSI PADA TIKUS HIPERTENSI YANG DIINDUKSI MONOSODIUM GLUTAMAT

ABSTRACT Previous studies accomplished that the chayote ethanol extract (Sechium edule (Jack) Sw) had an antihypertensive effect. To get and identify the active compound, we fractionated the extract and evaluated its antihypertensive activity. This study aims to investigate the antihypertensive effect of the n-hexane fraction (HF-CEE) and ethyl acetate fraction of chayote ethanol extract (EAF-CEE) in monosodium glutamate (MSG)-induced hypertensive rats. We made the chayote extract using the maceration method by soaking the chayote simplicia in ethanol 70%. HF-CEE and EAF-CEE were obtained by stratified fractionation using n-hexane and ethyl acetate. An antihypertensive effect of the fraction measured on MSG-induced hypertension male Wistar rats after MSG 100 mg/kg BW/day (p.o) treatment for 14 days. The study concluded that HF-CEE and EAF-CEE had an antihypertensive effect in MSG-induced hypertensive rats. The EAF-CEE antihypertensive effect is higher than HF-CEE. Therefore, the FEAF-CEE active compounds need to be isolated, identified, developed, and their potential as an antihypertensive candidate. Keywords: Antihypertensive, chayote, ethyl-acetate fraction, Sechium edule, monosodium glutamate

PENGARUH METODE EKSTRAKSI TERHADAP KADAR TOTAL FENOLIK, KADAR TOTAL FLAVONOID DAN AKTIVITAS ANTIOKSIDAN EKSTRAK DAUN MENGKUDU (Morinda citrifolia L.)

ABSTRACT Excessive Reactive Oxygen Species (ROS) can cause hypertension. Prevention of the risk of hypertension is consume an antioxidant. Noni (Morinda citrifolia L). is a plant that empirically proven to lower blood pressure and has antioxidant activity. Antihypertensive activity of noni leaves is influenced by phenolic and flavonoid compounds. The extraction method affects the levels of compound in extracts. The aims of study is determine the effect of the extraction method on the total phenolic level, total flavonoid level and antioxidant activity of noni leaf extract. The extraction methods are maceration, Microwave Assisted Extraction and Soxhlet. The results showed that the different extraction methods affected the total phenol level, total flavonoid level and antioxidant activity of the noni leaf extract. The Soxlet method provides the highest total phenolic level, total flavonoid level and antioxidant activity than other extraction methods. Keywords: Noni leaf extract, extraction method, total phenolic level, total flavonoid level and antioxidant activity

HUBUNGAN GENOTIPE rs 1042713 (Arg16Gly) DENGAN EFEKTIVITAS 2-AGONIS PADA PENDERITA ASMA

ABSTRACT To produce an effect, the agonist drug 2 will bind to the ADRB2 receptor. The effect of agonist 2 shows variation between individuals due to the presence of encoding gene polymorphisms. There are 80 ADRB2 polymorphisms, including Arg16Gly in amino acids 16. The innate ADRB2 genotype is called wildtype, whereas mutated ones is called mutant. The purpose of this study was to determine whether there was a relationship between genotype rs 1042713 (Arg16Gly) and the effectiveness of β2-agonist drugs in asthma sufferers. This study was an observational study with a cross sectional design and prospective data collection. Examination of the presence of gene polymorphisms and assessment of effe A total of 101 asthma patients who met the inclusion criteria were sorted by genome type by pharmacogenomic examination uses the Asthma Control Test (ACT) questionnaire. The results of the statistical test with chi square to determine the relationship of genome type and asthma control obtained p value 0.131. The comparison of the effectiveness of the wildtype genome is more effective than the mutant of 1.887x, and heterozygote is more effective 1,667x greater than the mutant. There is no significant relation between genotypes rs 1042713 (Arg16Gly) with effectiveness, but the possibility of clinical effectiveness is different. Keywords: Asthma, β2-agonist, ADRB2, genotype, effectiveness.

KUALITAS HIDUP PASIEN KANKER PAYUDARA DI RSUP DR. KARIADI SEMARANG MENGGUNAKAN KUISIONER EORTC QLQ-C30

ABSTRACT Breast cancer is the most common cancer found in women and is the dominant cancer in Indonesia. Cancer treatments such as chemotherapy can affect the quality of life of patients including physical, psychological, and social. The purpose of this study is to measure the quality of life of breast cancer patients. This research used cross sectional study design. The patient quality of life was measured using the EORTC QLQ-C30 questionnaire. The subjects of this study were breast cancer patients in RSUP Dr. Kariadi Semarang meeting the inclusion criteria. The cognitive function domain, social function, emotional function, role function, and physical function were 86,15 ± 17,82; 84,10 ± 21,13; 82,56 ± 17,72; 77,95 ± 29,77; 76,72 ± 22,95, respectively. Whereas in symptom scale group from pain, fatigue, insomnia, appetite loss, financial difficulties, nausea and vomiting, constipation, dyspnea and diarrhea were 32,82 ± 30,33; 32,65 ± 21,14; 31,79 ± 34,58; 31,79 ± 32,51; 30,77 ± 32,44; 23,59 ± 25,67; 17,95 ± 30,9; 4,62 ± 14,28; 4,10 ± 13,83, respectively. For global health status / quality of life obtained 72.18 ± 18.94. The highest score on the functional scale is the cognitive function domain and the lowest score is the physical function.On the scale of symptom the domain that has the highest score is the pain domain and the lowest score is the diarrhea domain. Keywords: quality of life, breast cancer, EORTC QLQ-C30

UJI EFEKTIVITAS EKSTRAK BUNGA KENOP (Gomprhrena globosa L) TERHADAP LUKA BAKAR PADA HEWAN UJI KELINCI (Oryctolagus cuniculus)

ABSTRACT The plant that is believed by the public as a medicinal plant is Globe Amarant (Gomprena globosa L) which allegedly contains flavonoids and saponins compounds that can modulate wound healing acceleration. The flower has been shown to have an effect on wound healing in test animals, but so far there has been no research on the effectiveness of the knob flower on burns. Therefore, this study aims to identify the content of flavonoids and saponins in Kenop flowers and to see the effectiveness of healing burns in rabbits. The design of this study was an experimental study that used 5 groups of test animals, namely 2 control groups, and 3 groups of Kenop flower extract. Burn induction was performed using a 2x2 plate. The length of the wound was measured every 2 days using a caliper. Meanwhile, the identification test of flavonoid and saponin compounds was carried out using the forth and wilstatter methods. Based on the results of the study, it was found that the ethanol extract of the Kenop flower contains flavonoid and saponin compounds. The effectiveness test of the Knob flower extract on burns showed that the 30% extract group showed 92% wound healing with a wound diameter on the 14th day of 0.16; followed by a 20% extract group with a wound healing percentage of 84.3% with a wound diameter of 0.31 cm. The ethanol extract of the flower of the Kenop flower can heal burns at that concentration. Keywords: Kenop Flower, Flavonoids, Burns

PENGANTAR REDAKSI

Assalamualaikum Wr.Wb Alhamdulillah seiring dengan perjalanan Fakultas Farmasi Universitas Wahid Hasyim Semarang, Jurnal Ilmu Farmasi dan Farmasi Klinik (JIFFK) telah memasuki tahun ke-17 semenjak penerbitan perdana tahun 2004. Kami tetap berharap bahwa JIFFK dapat memberikan kontribusi bagi perkembangan ilmu farmasi dan farmasi klinik. Kami berharap bahwa JIFFK ini dapat digunakan sebagai wadah bagi para peneliti, akademisi dan pemerhati ilmu farmasi dan farmasi klinik untuk mempublikasikan hasil penelitian atau pemikirannya. Demi menjaga eksistensi dan sustainabilitas JIFFK kami senantiasa memohon sumbangan tulisan atau artikel dari para peneliti. Kami selalu berusaha untuk dapat meningkatkan kualitas dari setiap penerbitan JIFFK ini, karena kami memiliki cita-cita supaya JIFFK dapat terakreditasi dari dikti. Akhir kata kami sampaikan terima kasih yang sebesar-besarnya kepada semua pihak yang telah membantu terlaksananya penerbitan ini. Kritik dan saran kami nantikan dari pembaca sekalian demi perbaikan dan kemajuan JIFFK. Wassalamu’alaikum Wr. Wb Semarang, Juni 2021 Hormat Kami Redaksi

PENENTUAN KADAR FLAVONOID TOTAL DAN NILAI SPF EKSTRAK ETANOL DAUN BUAS-BUAS (Premna serratifolia L.) ASAL KABUPATEN MELAWI PROVINSI KALIMANTAN BARAT

ABSTRACT Premna serratifolia L. leaves contain flavonoids, saponins, polyphenols, and terpenoids, potentially act as sunscreens. The purpose of this study was to determine the flavonoid content and SPF (Sun Protection Factor) ethanol extract of Premna serratifolia L. leaves from Melawi Regency, West Kalimantan Province using UV-Vis spectrophotometer. The Premna serratifolia L. leaves were extracted by maceration using 70% ethanol solvent, then the filtrate obtained was concentrated with a rotary vacuum evaporator to obtain a thick extract. The extract was determined for its flavonoid content using UV-Vis spectrophotometer at a wavelength of 439 nm, and the SPF value was determined at a concentration of 25, 50, 75, and 100 ppm with a UV-Vis spectrophotometer at a wavelength of 290-320 nm. The SPF value was calculated and analyzed descriptively using the Mansur method. The result showed that the average flavonoid content of ethanol extract of Premna serratifolia L. leaves was 3.70±0.02% calculated as quercetin. The SPF EEDB values obtained from variations in concentrations of 25, 50, 75, and 100 ppm respectively were 19.95±0.02; 30.08±0.01; 34.58±0.14; and 38.28 ± 0.12, where the SPF value is included in the ultra protection category. Key words: Premna serratifolia L. leaves, flavonoid content, SPF, UV-Vis Spectrophotometer

UJI DAYA ANTIINFLAMASI EKSTRAK ETANOLIK KULIT TERONG BELANDA (Solanum betaceum, Cav.) PADA MENCIT JANTAN YANG DIINDUKSI KARAGENIN

ABSTRACT Inflammation is a normal response to injury due to release of chemical mediators such as prostaglandins. Solanum betaceum Cav. skin contains flavonoid compounds. This study aims to determine the antiinflammatory power and the effect of variations in the dose of ethanolic extract of the skin of Solanum betaceum Cav on Swiss male strain mice caragenin-induced. The ethanolic extract of Solanum betaceum Cav skin was obtained using remaseration method with 96% ethanol solvent. Antiinflammatory power test using edema formation method with induction of caragenin 1% intraplantar 30 minutes before administration of the test material. Tests were carried out on 25 mice records which were divided into 5 groups namely negative control (0.5% CMC Na suspension), positive control (diclofenac sodium suspension in 0.5% CMC Na dose 7 mg/kgBW) and given suspension respectively. Dutch eggplant skin ethanolic extract in CMC Na 0.5% dose 70 mg/kgBW; 140 mg/kgBW; 280 mg/kgBW orally. The parameters observed were edema thickness measured using calipers at 30 minute intervals for 360 minutes. The results of edema thickness difference are used to calculate the Area Under Curve (AUC) and the percentage of antiinflammatory power (% AIP). Dat a were analyzed statistically with the One Way Anova test and continued by the Post Hoc Test with a 95% confidence level. The results showed that the ethanolic extract of Solanum betaceum Cav skin contains flavonoid compounds and has antiinflammatory power. The greater the dose of ethanolic extract of Solanum betaceum Cav skin, the greater the anti-inflammatory power. Keywords: Solanum betaceum Cav., antinflammation, caragenin

EVALUASI PENGGUNAAN OBAT PADA PASIEN OSTEOARTRITIS DI INSTALASI RAWAT JALAN RSUD DR. M. ASHARI PEMALANG PERIODE MARET-APRIL 2018

ABSTRACT Osteoarthritis (OA) is a degenerative joint illness characterized by cartilage destruction and often found on older people. The drugs commonly used to treat OA symptoms is paracetamol, nonsteroidal anti-inflammatory drugs (NSAIDs), food supplements such as glucosamine and chondroitin. The purposes of these studies are identifying the OA patient's characteristics (including gender and age), drug use evaluation based on the right patient, indication, and dose, as well as the potency of drug interactions on OA patients. This research is non-experimental research with a non-analytical descriptive design. The data was collected retrospectively with a purposive sampling method from outpatients OA medical records in RSUD Dr. M. Ashari Pemalang (March to April 2018 period). The results of this study indicate that patients have suffered OA for 1-2 years (40%), generally women (72.94%) with an age range of 46-55 years (39%). Most patients have an elementary school educational background (41%), and 43.53% of them are overweight (BMI 25.00-29.99). All medicines prescribed for OA patient therapy have been the right indication and patient. As many as 80.95% of the prescribed medicines had the right dose, and 19.05% of prescription drugs case categorized as underdosing. Drug interactions potency occurs in 30.58% of patients, with 29 cases. Keywords: Osteoarthritis, drugs use evaluation, outpatient